Vistin Pharma ASA (VISTN): Key information relating to the proposed cash dividend
The Board of Directors will propose for the AGM to get a power of attorney to pay-out an ordinary cash dividend of up to NOK 1.50 per share, to be paid partly with NOK 1 in May and up to NOK 0.50 in November, for the accounting year of 2025. The formal decision regarding the dividend will be made on the company's Annual General Meeting, which will be held on 20 May 2026.
Dividend amount (per share): NOK 1
Declared currency: NOK
Last day including right: 21 May 2026
Ex-date: 22 May 2026
Record date: 26 May 2026
Payment date (on or about): 29 May 2026
Date of approval: 20 May 2026
Key information relating to the second dividend payment which is planned in November will be communicated in due time.
For further information, please contact:
Alexander Karlsen
CFO
+47 97 05 36 21
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Latest Health & Supplement Reviews
- YuSleep Reviews (EXPOSED) Doctor Explains Deep Sleep Benefits, Hidden Risks & Real Consumers Results In 2026
- Neuro Energizer Reviews and Complaints 2026: How This Neuro-Sonic Breakthrough Is Reshaping Cognitive Therapy, Memory & Daily Focus
- Gluco6 Reviews and Complaints (March 2026) Real User Data on Natural Blood Sugar Balance and Glucose Stability